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Abstract
Background: An upper limb arteriovenous (AV) fistula is the access of choice for haemodialysis (HD). There have
been few reports of saphenofemoral AV fistulas (SFAVF) over the last 10-20 years because of previous suggestions
of poor patencies and needling difficulties. Here, we describe our clinical experience with SFAVF.
Methods: SFAVFs were evaluated using the following variables: immediate results, early and late complications,
intraoperative and postoperative complications (up to day 30), efficiency of the fistula after the onset of needling
and complications associated to its use.
Results: Fifty-six SFAVF fistulas were created in 48 patients. Eight patients had two fistulas: 8 patent (16%), 10
transplanted (20%), 12 deaths (24%), 1 low flow (2%) and 20 thrombosis (39%) (first two months of preparation).
One patient had severe hypotension during surgery, which caused thrombosis of the fistula, which was successfully
thrombectomised, four thrombosed fistulae were successfully thrombectomised and revised on the first
postoperative day. After 59 months of follow-up, primary patency was 44%.
Conclusion: SFAVF is an adequate alternative for patients without the possibility for other access in the upper
limbs, allowing efficient dialysis with good long-term patency with a low complication rate.
Background
The establishment of vascular access for hemodialysis
(HD) remains a challenge for vascular surgery. Due to
the improvement of chronic renal failure treatment and
consequently, increased survival, maintenance of vascu-
lar access and long-term treatment of its complications,
it has become an important cause of hospitalization,
morbidity and patient costs [1,2].
The access of choice for HD is a primary arteriove-
nous (AV) fistula in the upper limb, between the radial
artery and the cephalic vein [3-6]. This technique
increases venous flow approximately 250-300 ml per
minute, which is the minimum flow velocity needed to
obtain the appropriate clearance of urea after 4 hours of
HD. The preference for its use is due to the longer per-
iod of working of these AV communications, low rate of
complications and easy handling [7-9]. Prolonged use of
these accesses may lead to complications such as
infection, puncture pseudoaneurysm, anastomotic pseu-
doaneurysm, venous hypertension, distal ischemia and
their own obstruction [10]. In this situation, generally
creation of new AV fistula is indicated.
Some disadvantages of using AV fistula by transposi-
tion of the femoral vein are the necessity for a more
extensive and deeper dissection that uses larger vessels
and make it more susceptible to infection and steal syn-
drome [11]. Such problems were also observed by us
[12] and motivated us to seek a new alternative techni-
que, using a saphenous vein in “bridge”; conformation,
anastomosed to the superficial femoral artery near the
adductor canal [12]. The initial benefits of this proce-
dure encouraged us to expand the study with a larger
patient number, analyzing the results of clinical experi-
ence and late complications. Therefore, in view of the
above considerations, we aimed to evaluate the results
of saphenofemoral AV fistula (SFAVF) as access to HD.
Method
This is a longitudinal prospective study conducted at the
Hospital of the Faculdade de Medicina do ABC, in São
* Correspondence: cor.jantonio@gmail.com
1Departamento de Cirugia da Faculdade de Medicina do ABC, Santo André,
SP, Brasil
Full list of author information is available at the end of the article
Correa et al. BMC Surgery 2010, 10:28
http://www.biomedcentral.com/1471-2482/10/28
© 2010 Correa et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Bernardo do Campo (SP). The patients were from the
Department of Nephrology, Faculdade de Medicina do
ABC, São Bernardo do Campo (SP), and from the
Nephrology and Hypertension Center, Santo André
(SP). We included patients in whom all access possibili-
ties were exhausted in the upper limbs and could not be
treated by peritoneal dialysis, while those with an absent
or inadequate long saphenous vein, sequelae of deep
venous thrombosis or a femoropopliteal arterial occlu-
sion were excluded.
This research was explained to all subjects and it was
begun only after their consent according to the stan-
dards of the Ethic Committee in Research of our Uni-
versity (protocol number 021/2000). All patients gave
informed consent. All procedures were in compliance
with the Helsinki Declaration.
From August 1998 to May 2006 1183 fistulas for HD
access were performed. 1086 were native (91.8%) and 97
(8.2%) were prosthetic polytetrafluoroethylene (PTFE).
Among the 1086 native, 1030 (87.1%) were performed
in upper limbs and 56 (4.7%) in lower limbs and used
the saphenous vein. Among the fistulas which used
prostheses, 79 (6.7%) were performed in upper limbs
and 18 (1.5%) in lower limbs.
The 56 SFAVF were performed in 48 patients who
underwent HD, in which all access possibilities were
exhausted and limbs met the inclusion criteria. Data
from each patient were recorded in a protocol for
further statistical evaluation.
The sample consisted of 27 female (56.2%) and 21
male (43.7%) patients. In eight patients (6 women and 2
men) two SFAVF were performed, these were performed
at the same time. Ages ranged from 10 to 82 years old
(mean 44.4 years old). One 10-year old patient was of
small stature and had no
One 10-year old patient was of small stature and had
no vessels of an appropriate size. Among the 48
patients, 42 (87.5%) presented one or more associated
diseases such as hypertension (HT), diabetes mellitus
(DM), heart and arterial diseases.
We conducted analysis of cumulative patency by
Kaplan-Meier method and other results were presented
as a simple percentage.
The surgical technique consisted of making an AV fis-
tula by using only one anastomosis between the saphe-
nous vein and the distal superficial femoral artery after
its implementation and superficial to the anterior thigh.
Patients were discharged on the first day after surgery
after verification of clinical conditions and surgical out-
comes. The follow-up was performed on an outpatient
basis, every seven days in the HD unit. Thirty days later
the fistula was released to punctures.
Fistulas were evaluated according to puncture, HD
flow, spontaneous venous pressure absence and dialysis
adequacy according to weekly Kt/v [13]. Puncture facil-
ity was defined as catheterization of the fistula at its
first attempt, the minimal acceptable HD flow was con-
sidered as values above 250 ml/min; absence of sponta-
neous venous pressure was considered as pressure lower
than 100/mm Hg at the end of devolution with optimal
blood flow and urea clearance dialysis adequacy (in
vitro) was multiplied by the duration of dialysis in min-
utes divided by the volume of urea distribution (weight
× 0.6). We considered 1.2 as the ideal week value.
We also evaluated the presence or absence of compli-
cations such as thrombosis, post-puncture hematoma,
distal limb ischemia, venous hypertension, cardiac
decompensation, infection, puncture pseudoaneurysm,
anastomotic pseudoaneurysm and aneurysmal dilatation.
If a problem was found we used ultrasonography and
Echo-color-Doppler 2P. In cases of stenosis we treated
with an angioplasty and in cases of pseudoaneurysm we
performed a surgical revision.
The immediate result was defined as thrill intensity
and presence or absence of postoperative complications
after surgery. Regarding fistula maturation we consid-
ered early outcome as the fistula maturation from the
1st to the 30th post-operative day and late result as the
fistula maturation after punches onset (after the 30th
post-operative).
Technical Standardization
Patients were submitted to SFAVF creation according to
the following standardization: (1) Election of the most
suitable limb for manufacture of AV fistula through
clinical examination based on arterial and venous condi-
tions: presence of normal peripheral pulses and no signs
of chronic venous hypertension or varicose vein disease.
(2) Patient on horizontal dorsal supine position under
spinal anesthesia. (3) Antisepsis with iodopovidine and
delimitation of the surgical area with sterile cloths (Fig-
ure 1). (4) Longitudinal incision of approximately 6 cm
in the inguinal region, dissection and ligation of tribu-
tary veins of the proximal saphenous vein. (5) Stab inci-
sions for dissection of the saphenous vein to its distal
third of the thigh (Figure 2). (6) Oblique incision of
approximately 10 cm in the middle third of the distal
inner thigh. (7) Dissection of the distal thigh followed
by planes of dissection and isolation of the superficial
femoral artery above the hiatus of the adductor magnus
medially away from the sartorius muscle (Figure 3). (8)
Distal ligation, removal of the bed with plastic tube
catheterization number six and heparinization of the
saphenous vein with 20 ml of heparin 1% (Figure 4). (9)
Production of subcutaneous tunnel by blunt dissection
in the anterolateral thigh in order to place the saphe-
nous vein in front of its new bed. (10) Proximal and dis-
tal superficial femoral artery clamp and longitudinal
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arteriotomy of approximately 1 cm. (11) Proximal
heparinization with 10 ml of heparin to 1%, end-to-side
saphenous vein to the femoral artery, using running
sutures of 6-0 polypropylene. (12) Arterial and venous
unclamp according to maneuvers and pulmonary
embolic protection. (13) Passage of the saphenous vein
through the subcutaneous tunnel (Figure 5). (14) Verifi-
cation of the final terms, as the conformation of the
vein and the thrill of the proximal and distal AV fistula.
Figure 6 represents the anastomosis between the saphe-
nous vein and superficial femoral artery and Figure 7
presents the final aspect of the surgical scars.
Results
Fifty-six fistulas were used in 48 patients, 27 females
and 21 males. Six patients underwent construction of
two saphenous vein fistulas (four females and two
males). The oldest is in operation for 59 months and
the youngest for three months. These fistulas were effi-
cient, did not present difficulty to puncture, presented
good HD flow (300 ml/min), presented no spontaneous
venous pressure and dialysis adequacy according to kt/v
(within the ideal value) [13].
Ten patients underwent renal transplantation with
cadaver kidney (20.8% - seven females and three males).
The age ranged from 24 to 51 years old (mean 34.7
years old). These transplants occurred from the 3rd to
the 37th month after fistulas creation (average of 9.6
months) (Table 1).
In this follow-up of 59 months, among the 56 fistulas
that were used in 48 patients we found four types of
complications: thrombosis, pseudoaneurysm, stenosis/
low flow and puncture hematoma. Thrombosis and low
flow with functional loss occurred in 21 fistulas (41.2% -
11 were male and 10 female patients). The working
period of the fistula ranged from two to 30 months
(average of 9.5 months of use). The age ranged from 10
to 80 years old (average of 43.3 years old). Pseudoaneur-
ysm puncture occurred in five fistulas (9.8% - all
patients were female). The earliest occurred in four
months and the latest occurred after 30 months of use.
Stenosis with low flow fistulas occurred in two cases
(5.9% - one male and one female) with a mean time of
seven months. Puncture hematoma occurred in a fistula
Figure 1 Patient positioned for surgery with demarcation of
the planning technique.
Figure 2 Dissection of the saphenous vein through stab
incisions, starting from the inguinal region to the distal third
of thigh.
Figure 3 Dissection of the superficial femoral artery above the
adductor canal.
Figure 4 Saphenous vein dissected, it was removed from its
bed and was catheterized.
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in a female patient at the 3rd month of its maturation
and its absorption occurred spontaneously without jeo-
pardize the fistula patency. Other complications such as:
ischemia, venous hypertension, infection, anastomotic
pseudoaneurysm, aneurysmal dilatation and cardiac
decompensation were not observed.
After treatment of complications, these fistulas could
be used for a varied period until the following outcomes
occured: maintenance of patency, transplantation, death
or thrombosis.
In cases of patients with thrombosis or low flow (21
fistulas, eight subjects), it was decided to carry out
SFAVF in the contralateral limb, and in two, both male,
we decided to implant a PTFE in bridge, using the
superficial femoral artery and common femoral vein of
the contralateral limb. In another case, also male, we
also decided by the PTFE to implant in “loop” using the
common femoral artery and vein in the inguinal region
in the same limb which the SFAVF was performed. In
the same condition it was held biopsy of the saphenous
vein thrombosis of the anterior fistula.
In other cases of thrombosis due to the urgent neces-
sity for HD it was decided to install double-lumen
catheter (perm-cath®) through the femoral vein in the
inguinal region. In only two cases was it possible to per-
form peritoneal dialysis.
In 93 months of follow-up there were twelve deaths in
patients who had their SFAVF able (eight females and
four males), the youngest was 37 years old and the old-
est 80 years old, with an average of 50 years. The
maturation period of these fistulas ranged from two to
40 months, with an average of 16.6 months.
At this time eight fistulas continue to be used in four
females and four males, the youngest aged 30 years old
and the oldest aged 53 years old (average of 42.9 years
old). The most recent has three months of operation
and the oldest 59 months (average of 16 months). Since
the beginning of the investigation until now, we have
experienced eight patent fistulas, 10 transplant patients,
12 deaths, 20 thromboses and one low flow.
We carried out the analysis of cumulative patency
[14], with a score of 44.04% patency likely at the end of
the period of 59 months, which is the duration of the
Figure 5 Passage of the saphenous vein through the
subcutaneous tunnel on the anterior thigh.
Figure 6 Anastomosis between the saphenous vein and
superficial femoral artery
Figure 7 Final aspect of the surgical scars.
Table 1 Distribution of SFAVF according to analysis after
93 months of follow-up (N = 51)
Development Number of fistulas %
Functioning 8 15.7
Transplanted 10 19.8
Deaths 12 23.5
Thrombosis 20 39.2
Low flow 1 1.9
% = Percentage.
N = Number.
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oldest fistula operation. We observe in Figure 8 cumula-
tive patency curve by the Kaplan-Meier method in 59
months and in Figure 9 we observe cumulative patency
curve by the Kaplan-Meier method in 59 months
excluding primary failures.
By eliminating the primary failure, i.e., fistulas throm-
bosis in the first two months of preparation, according
to the recommendations of the National Kidney Foun-
dation (NKF)-Dialysis Outcomes Quality Initiative
(DOQI) Clinical Practice Guidelines for Vascular Access,
1997, it was withdrawn from analysis nine fistulas (seven
thromboses and two due to death), we obtained then a
patency of 51.04% in this period.
In all cases the primary (five pseudoaneurysms and
three stenosis) and second (one thrombosis) patencies
were maintained.
Discussion
According to our findings, SFAVF was a viable option in
patients without vascular access options in upper limbs
and it presented good efficacy, low morbidity,
complications which could be corrected and good
patency rate in long term.
The choice of anastomosis site in the distal superficial
femoral artery above the adductor canal was decided in
order to avoid kinking of the saphenous vein during its
accommodation in the subcutaneous tunnel [15] and
also to keep it away from the inguinal region, where the
risk of infection is higher [15]. Another advantage is
that artery is easily accessible and makes it easier to per-
form anastomosis. In this technique, anastomosis is pro-
tected by the sartorius muscle, hence avoiding close
punctures and decreasing the risk of anastomotic
pseudoaneurysms.
The “bridge” technique with the superficial anterior
saphenous vein offers facilities to punctures; it is a long
vein segment, thus avoiding repeated punctures at the
same location, which minimizes the risk of pseudoa-
neurysms, thrombosis and early stenosis [16]. Further-
more, based on our experience, it also enables the
patient to a comfortable and safe position during HD.
The most serious and common complication in this
study was thrombosis, however, when it was performed
during the intraoperative period until the first post-
operative day, whether by technical failure, severe hypo-
tension or compression by hematoma due to
coagulation disorders, it was corrected instantly through
a new surgical approach restoring the fistula patency.
This procedure was necessary in five fistulas in our
study, one occurred in the intraoperative period and
four on the first days after surgery, and these fistulas
were used later.
At late follow-up, i.e. 30 days after fistula creation,
among the 56 fistulas that were used there were 21
losses, 20 by thrombosis and reduced blood flow, with
time course ranging from two to 30 months; the largest
number of thrombosis occurred in the first two months
(33.3%). The higher thrombosis concentration in this
period reminds us that this fact is also observed in all
other forms of native fistulas, especially in the wrist
radio-cephalic AV fistula [17], which follows as the stan-
dard reference of vascular access for HD, and it presents
a high rate of early or immediate failure, ranging from
10 to 30%, reaching some groups nearly 50% and it pre-
sents high risk for diabetics in elderly and women [18].
The losses caused by late thrombosis and decreased
blood flow occurred in 14 fistulas, it probably occurred
in many of these cases due to multiple punctures at the
same location, leading to stenosis, low flow and subse-
quent thrombosis [17]. The suspicion of repeated punc-
tures could be observed by clinical examination, where
patients presented an area of skin nodules hypopigmen-
tation and hard nodule in the vein segment at the corre-
sponding region. In the pathological examination
performed in a vein fragment of a patient it was found
Figure 8 Cumulative patency curve by the Kaplan-Meier
method in 59 months (±5.49%; N = 51).
Figure 9 Cumulative patency curve by the Kaplan-Meier
method in 59 months excluding primary failures (±6.36%;
N = 42).
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myointimal hyperplasia of the vein, which demonstrates
thickening of venous wall.
We observed some cases of thrombosis due to pro-
longed arterial hypotension and one case due to trauma
of the fistula site at home environment. By studying this
type of complication, we alert to the importance of
maintaining regular surveillance with periodic evaluation
of these fistulas in order to detect early dysfunction so
that it may be corrected in time, reducing the risk of
thrombosis and increasing the usefulness period of the
AV fistula [19].
Puncture pseudoaneurysm occurred in five fistulas
(9.8%). It may be clinically diagnosed and confirmed by
fistulography and ultrasound. This complication was
probably due to inadequate compression of the puncture
site after dialysis sessions associated with repeated punc-
tures in one place, leading to vein wall weakness. None-
theless, this type of complication was possible to be
corrected in three cases. In two cases it was corrected
through its resection and interposition of a new vein
segment while in the third case it was corrected by
resection and placement of a venous patch, maintaining
the primary patency. Vigilance with regard to this com-
plication should be intense. When skin is affected the
risk of rupture is too large and should therefore be per-
formed surgical correction as early as possible in those
situations [20].
We observed one case of post-puncture hematoma
due to compression and inadequate care after dialysis
session. This fistula may be preserved through clinical
treatment and by spontaneous absorption of the hema-
toma; however, the risk of an infection is always high in
such cases. It may be necessary in some cases to per-
form surgical drainage.
Stenoses were detected by flow decrease during dialy-
sis session. These situations could be confirmed by fistu-
lography, through digital subtraction in three cases. This
complication could be corrected in two cases by endo-
vascular therapy through percutaneous transluminal
dilatation, which maintained the fistula patency. More-
over, its use may be retaken one day after this proce-
dure. Therefore, to correct stenosis with hemodynamic
repercussion in this type of access as well as in other
grafts access types it should be made as early as possible
in order to keep an adequate dialysis to decrease throm-
bosis rate and consequently increase the survival.
When it is impossible to correct thrombosis, the crea-
tion of a new SFAVF in the contralateral limb may be
indicated, since the saphenous vein and superficial
femoral artery allow it. This option was used in eight
patients in our investigation. In some cases of thrombo-
sis, which the long saphenous vein of the contralateral
limb was already used, it was necessary to use PTFE in
bridge by using the superficial femoral artery and distal
common femoral vein in the inguinal region. In case of
saphenous vein absence, this was our first choice
because there was facility to accommodate the prosthe-
sis in subcutaneous tissue.
The option to implant a PTFE “in loop” using com-
mon femoral artery and vein in the inguinal region, as
performed by Khadra et al [17] and Bhandari et al [16],
was our last choice, we executed it in cases that it was
already performed in the same SFAVF limb and the
contralateral limb was unable to use the saphenous vein
and to implant PTFE in bridge. In some cases we used
this technical option to prevent fibrosis in the anterior
region of the anastomosis between the superficial
femoral vein and artery, thereby avoiding the creation
of a new “bridge” fistula conformation. Notwithstanding,
this technique presents high infection rate as reported
by Bhandari et al [16], who presented infection range of
35% and Khadra et al [17], who showed infection rate
of 16%.
Other complications such as distal ischemia, venous
hypertension, cardiac decompensation, anastomotic
pseudoaneurysm, aneurysmal dilatation, infection or
other complications were not observed in our experi-
ence. Conversely, Taylor et al [22] performed 45 grafts
(“in loop” and “in thigh”), in whom PTFE prosthesis
were used in 39 cases and bovine carotid artery in six
cases. They observed high rate of non-thrombotic com-
plications with 18% of infection and 16% of distal limb
ischemia.
A new analysis was done after exclusion of primary
failure, i.e. the losses in the first two months of its crea-
tion, as recommended by various conduct guidelines for
vascular access (NKF-DOQI, Spanish Society of
Nephrology). This analysis showed that the rate
increased to 51.04% in 60 months in 42 fistulas. On the
other hand, analysis of results after 12 and 24 months
revealed a patency rate of 78.2% and 63.8% respectively,
a rate close to researches published by Brescia and
Cimino [18], which primary patency at six months ran-
ged between 65% and 81%.
The limitation of this technique is given in cases when
the patient presents saphenous vein absence or when
the saphenous vein is inadequate for this purpose and
also in patients with arterial occlusive disease in the
femoropopliteal territory. Another limitation of this
technique is that the saphenous vein prevents the devel-
opment of the fistula due to its developed muscle layer,
similar to the cephalic vein in the internal forearm AV
fistula. Although it prevents aneurysmal dilatation it
increases the risk of myointimal hyperplasia after
repeated punctures of the AV fistula [20]. Nevertheless,
because it is autologous material, presents low cost,
higher infection resistance and it is easy to handling, the
advantages compensate its limitations even when
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compared to other access techniques in lower limbs
which also uses autologous material such as transposi-
tion of the superficial femoral vein, first described by
Huber et al [23], which reported two cases of use of this
vein, one in the thigh and one in the arm and also
reported by Gradman et al [24], in a retrospective study
of 25 cases, which used this technique in lower limbs.
This technique, which is an exception procedure,
showed very good results in its long-term use according
to our findings.
Conclusion
Saphenofemoral arteriovenous fistula is a viable alterna-
tive in patients which present no more options for vas-
cular access in upper limbs. It presents good efficacy,
low morbidity, complications that may be corrected and
good patency rate in long term.
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